Palatin Technologies to Report Fiscal Year 2009 First Quarter Results; Conference Call and Webcast on November 17, 2008

Date : 11/13/2008 @ 10:06AM
Source : PR Newswire
Stock : Palatin Technologies, (PTN)
Quote : 0.27  0.0085 (3.25%) @ 8:00PM
<< BackQuote Chart Financials

 



Palatin Technologies to Report Fiscal Year 2009 First Quarter Results; Conference Call and Webcast on November 17, 2008

CRANBURY, N.J., Nov. 13 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (AMEX:PTN) will announce its first quarter, fiscal year 2009 financial results on Monday, November 17, 2008 before the open of the U.S. financial markets.

The Company will also conduct a conference call and live audio webcast hosted by Palatin's executive management team on November 17, 2008 at which they will discuss the results of operations in greater detail and provide an update on corporate developments.

Schedule for the Financial Results Press Release, Conference Call and Webcast

-- Q1-Fiscal Year 2009 Financial Results Press Release 11/17/2008 at 7:30 a.m. ET

-- Q1-Fiscal Year 2009 Conference Call - Live 11/17/2008 at 11:00 a.m. ET

Domestic Dial-In Number 1-888-263-2919 International Dial-In Number 1-913-312-0381 Passcode: 7115648

-- Q1-Fiscal Year 2009 Conference Call -- Replay 11/17-11/24/2008

Domestic Dial-In Number 1-888-203-1112 International Dial-In Number 1-719-457-0820 Replay Passcode: 7115648

-- Webcast Live and Replay Access http://www.palatin.com/

The webcast and replay can be accessed by logging on to the "Investor/Media Center-Webcasts" section of Palatin's website at http://www.palatin.com/.

About Palatin Technologies, Inc.

Palatin Technologies, Inc. is a biopharmaceutical company dedicated to the development of peptide, peptide mimetic and small molecule compounds with a focus on melanocortin and natriuretic peptide receptor systems. The melanocortin system is involved in a large and diverse number of physiologic functions, and therapeutic agents modulating this system may have the potential to treat a variety of conditions and diseases, including sexual dysfunction, obesity and related disorders, ischemia-reperfusion injury, hemorrhagic shock and inflammation-related diseases. The natriuretic peptide receptor system has numerous cardiovascular functions, and therapeutic agents modulating this system may be useful in treatment of heart failure, hypertension and other cardiovascular diseases. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin Technologies' website at http://www.palatin.com/.

DATASOURCE: Palatin Technologies, Inc.

CONTACT: Stephen T. Wills, CPA, MST, EVP-Operations, Chief Financial

Officer of Palatin Technologies, Inc., +1-609-495-2200, , or

Institutional Investors and Media, Susan Kim of Burns McClellan,

+1-212-213-0006,

Web site: http://www.palatin.com/

<< Back


Palatin Technologies, Historical Chart Palatin Technologies, Intraday Chart  
Period


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2009 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
33 site:2us 091126 05:01 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 )